LONDON, June 30, 2022 /PRNewswire/ — Kanna Wellbeing Ltd (Kanna Well being) – Right now, the Environment Intellectual House Place of work has published Kanna Health’s patent application covering the use of KH-001 as a treatment for untimely ejaculation, entitled “Solutions for hold off of ejaculation in human males” (WO/2022/140417).
KH-001 is a distinctive proprietary type of a naturally-developing alkaloid. Scientists at Kanna Overall health have elucidated the pharmacological targets of KH-001. Primarily based on these information, Kanna Health shown that KH-001 substantially delays ejaculation in a dose-dependent way. KH-001 exhibits a quickly onset of motion, enabling a viable on-demand procedure for premature ejaculation, and represents a probable breakthrough in the treatment method of a illness with a large unmet health care want.
Kanna Health’s President and inventor on the patent application, Dr Ryan Protzko, mentioned “The information in our patent application show that KH-001 has huge probable as a treatment method for untimely ejaculation. The pharmacological profile of our compound is preferably suited to an acute, on-demand from customers medication that treats premature ejaculation.”
To date, there are no authorised therapies for untimely ejaculation in the US.
Just one of Kanna Health’s scientific advisory board customers, Dr. Andrea Burri, shared: “Untimely ejaculation is a distressing affliction, in which men orgasm much too immediately just before or throughout sexual intercourse. There are at the moment no treatments permitted by the Fda, even while it has an effect on up to 20% of adult men. These adult men report decreased ranges of sexual performing and pleasure, diminished self-esteem, and increased stages of own distress. Associates of these adult men also endure, and report sexual dissatisfaction and frustration, as properly as troubles in the connection.”
John Boghossian, Kanna Health’s CEO, said: “We are actually thrilled about this info and our improvement programme for KH-001. Primarily based on the proof we have to day, we believe KH-001 could characterize a significant breakthrough in the remedy of premature ejaculation. There is a significant unmet professional medical need to have for a harmless, efficacious on-demand from customers procedure of premature ejaculation. We are advancing KH-001 into scientific development to tackle that need. This software complements the more patent purposes we have submitted shielding KH-001.”
About Premature Ejaculation
Untimely ejaculation is the most widespread variety of male sexual dysfunction (Carson & Gunn, IJIR, 18, S5-S13 (2006)). Adult males with untimely ejaculation can feel stigmatised, and as a consequence, the true prevalence is likely to be bigger than 20%. In addition to the bodily signs or symptoms, premature ejaculation frequently will cause anxiousness and emotional distress to affected folks and usually adversely impacts the connection with their sexual spouse.
About Kanna Well being Ltd
Kanna Health and fitness is a preclinical-stage biopharmaceutical firm. Kanna Health and fitness is establishing novel medicines for places of unmet healthcare will need, derived from and inspired by the alkaloids observed in Sceletium tortuosum (kanna). Kanna has been applied for temper and performance enhancement applications by the San and Khoikhoi communities in South Africa for hundreds of several years.
More details:
For further information, remember to get hold of John Boghossian, [email protected], +44 ()7400 964226
Check out authentic content:https://www.prnewswire.com/information-releases/kanna-well being-announces-publication-of-patent-application-for-kh-001-as-a-remedy-for-premature-ejaculation-301578852.html
Source Kanna Well being Ltd
More Stories
Unveiling the Essence: Indonesian Pharmacy Association (PAFI) Banyuasin
The Green Mediterranean Diet Helps to Improve Proximal Aortic Stiffness
Let’s Talk Medical Gaslighting: A Panel Discussion